COVID-19 Vaccine Development

Our Science
COVID-19 Vaccine Development

COVID-19 Vaccine Development

Rapid progress on the path to develop, test and manufacture a vaccine

COVID-19 INFORMATION AND RESOURCES

Your Health
man_lab_dark_380x500.png
man_lab_dark_1000x450_0.jpg

COVID-19 INFORMATION AND RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

WE STAND WITH SCIENCE

Your Health
We_stand_with_science_pledge_380X500
We_stand_with_science_pledge_1000X450

WE STAND WITH SCIENCE

Pfizer and other leading pharmaceutical companies pledge to develop COVID-19 vaccines that adhere to well-established and validated scientific standards and call on the public to stand with us.

STEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSIS

Your Health
Managing_Finances_After_Cancer_Diagnosis_790X500
Managing_Finances_After_Cancer_Diagnosis_1000x450.jpg

STEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSIS

Cost should never be a barrier to receiving cancer treatment, yet there are people who forgo treatment so as not to burden their family with high medical costs.

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

Your Health
Maintaining_Positivity_790x500.png
Maintaining_Positivity_1000x450.jpg

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

In recognition of Pain Awareness Month, Ann and her daughter Elizabeth (Lizzie) Sullivan sat down with Grace Whiting, President & CEO of the National Alliance for Caregiving, to discuss the impact that chronic pain due to OA can have.

Latest News

Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the U.S. Food and Drug Administration (FDA). PF-06939926 is currently being evaluated to determine the safety and efficacy of this gene therapy in boys with DMD. Fast Track is a process designed to facilitate the development, and expedite the review, of new drugs that are intended to treat or prevent…